Specialist Working Group for Neurology Proposed changes to the Criteria for the clinical use of intravenous immunoglobulin in Australia, Second Edition ITEM CRITERIA FOR THE CLINICAL USE OF PROPOSED REVISIONS TO THE CRITERIA SWG RATIONALE FOR INTRAVENOUS IMMUNOGLOBULIN IN PROPOSED CHANGE AUSTRALIA, SECOND EDITION (CRITERIA) (A) Administrative) (B) Progressive (C) Programmed Condition Opsoclonus-myoclonus ataxia (OMA) Opsoclonus-myoclonus ataxia (OMA) Name Specialty Neurology Neurology Chapter 6 Specific Idiopathic Conditions Paraneoplastic associated neuroblastoma Paraneoplastic associated small cell lung cancer Paraneoplastic associated breast cancer Paraneoplastic associated other tumour type Level of Small case studies only; insufficient data Small case studies only; insufficient data Evidence (Category 4a). (Category 4a).
Specialist Working Group for Neurology Proposed changes to the Criteria for the clinical use of intravenous immunoglobulin in Australia, Second Edition ITEM CRITERIA FOR THE CLINICAL USE OF INTRAVENOUS IMMUNOGLOBULIN IN AUSTRALIA, SECOND EDITION (CRITERIA) PROPOSED REVISIONS TO THE CRITERIA SWG RATIONALE FOR PROPOSED CHANGE (A) Administrative) (B) Progressive (C) Programmed Condition Name Opsoclonus-myoclonus ataxia (OMA) Opsoclonus-myoclonus ataxia (OMA) Specialty Neurology Neurology Chapter 6 Specific Conditions Idiopathic Paraneoplastic associated neuroblastoma Paraneoplastic associated small cell lung cancer Paraneoplastic associated breast cancer Paraneoplastic associated other tumour type Level of Evidence Small case studies only; insufficient data (Category 4a). Small case studies only; insufficient data (Category 4a).
opsoclonus-myoclonus-ataxia-oma.DOCX